Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06924970 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 56 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Agios Pharmaceuticals, Inc. |
| Last Updated on CT.gov | January 28, 2026 (Jan 28, 2026) |
As of March 2, 2026: Clinical trial NCT06924970 is currently recruiting participants. This clinical trial study for sickle cell disease is actively seeking new participants at 5 locations across the United States. The study is sponsored by Agios Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06924970 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06924970 was last updated Jan 28, 2026 (January 28, 2026). HelloStudys verifies this status automatically.